Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





Income Statement
Balance Sheet
Cash Flow Statement
Segments

Common Size IS
Op Efficiency
Credit Analysis

GENEREX BIOTECHNOLOGY CORP (GNBT)

Income Statement

Standardized | As Reported Annual | Quarterly | TTM
  Older >>
In millions, except per share itemsApr-30-21Jan-31-21Oct-31-20Jul-31-20Apr-30-20Jan-31-20Oct-31-19Jul-31-19
   10-Q10-Q10-Q10-K10-Q10-Q10-Q10-K
Total revenues   [+]0.00.00.02.70.00.00.06.2
            Revenue growth  -100.0%-100.0%-100.0%-57.1%-99.8% -93.2%784.4%
Cost of goods sold  0.00.10.1-1.10.40.70.62.0
Gross profit  0.0-0.1-0.13.7-0.4-0.7-0.64.2
            Gross margin     140.6%-7647480.0%-108739.8%-129898.0%67.2%
Selling, general and administrative   [+]6.38.514.23.64.05.35.32.5
Research and development     2.1   1.7
Other operating expenses  0.0-0.1-0.11.0-0.4-0.7-0.65.6
EBITDA   [+]-6.1-8.2-13.9-2.7-3.8-5.0-5.1-5.9
            EBITDA margin     -101.5%-75097340.0%-794577.0%-1131201.1%-94.7%
Depreciation  0.00.00.00.00.00.00.0-0.1
EBITA  -6.1-8.2-13.9-2.7-3.8-5.1-5.2-5.7
            EBITA margin     -102.7%-76076000.0%-802282.8%-1142008.0%-92.7%
Amortization of intangibles  0.20.20.20.20.20.20.20.0
EBIT   [+]-6.3-8.5-14.2-2.9-4.0-5.2-5.3-5.7
            EBIT margin     -109.8%-79134660.0%-826682.2%-1176173.0%-92.7%
Non-recurring items   [+]   0.9   -0.3
Interest expense, net   [+]   7.1   7.0
Other income (expense), net   [+]7.49.115.2-23.35.56.77.81.5
Pre-tax income  0.00.00.0-34.20.00.00.0-11.0
Income taxes  0.00.00.00.00.00.00.00.0
            Tax rate     0.0%   0.0%
Minority interest     -0.9   -1.7
Net income  0.00.00.0-33.30.00.00.0-9.3
            Net margin     -1253.1%0.0%0.0%0.0%-150.7%
   
Basic EPS   [+]$0.00$0.00$0.00($0.46)$0.00$0.00$0.00($0.14)
Diluted EPS   [+]$0.00$0.00$0.00($0.46)$0.00$0.00$0.00($0.14)
   
Shares outstanding (basic)   [+]114.6110.196.973.177.065.669.867.7
Shares outstanding (diluted)   [+]140.4110.196.973.177.065.669.867.7
   
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.  

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy